DataMEDS AI, Inc. (NasdaqCM: MEDS)
Health Care · Health Care Providers & Services · US
$1.36
-8.11% today · -96.1% 1Y
DataMEDS AI, Inc. (NasdaqCM: MEDS) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $3.71M and employs 31 people.
Over the last twelve months the share price has lost 96.1%, trading between 1.90 and 97.50.
Tweenvest scores DataMEDS AI, Inc. across four factors: quality 12/100, value 61/100. Its strongest factor is value.
MEDS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.71M
- Revenue (TTM)
- $14.03M
- P/E
- —
- EPS
- -45.50
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $97.50
- 52-week low
- $1.90
- Avg volume (3M)
- —
- Shares outstanding
- 2.51M
- Employees
- 31
- Next earnings
- —
About DataMEDS AI, Inc.
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
- ISIN
- US9495032057
- Founded
- 2022
- Listed since
- Feb 21, 2025
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $396.59 | -0.54% |
| CVS Health CorporationNYSE: CVS | $118.82B | $92.90 | -1.29% |
| McKesson CorporationNYSE: MCK | $105.52B | $905.09 | +3.58% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $428.76 | -0.11% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $398.87 | -0.93% |
| The Cigna GroupNYSE: CI | $73.81B | $279.32 | -0.40% |
| Cencora, Inc.NYSE: COR | $62.60B | $328.06 | +1.33% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $237.92 | +2.39% |
Figures last refreshed Aug 18, 2026.